| Autor: |
Al-Ahmad, Mona, Al Rasheed, Mona, Shalaby, Neveen, Rodriguez-Bouza, Tito, Altourah, Lulwa |
| Předmět: |
|
| Zdroj: |
Clinical & Applied Thrombosis/Hemostasis; Jan-Dec2022, Vol. 28, p1-3, 3p |
| Abstrakt: |
Significance Statement This paper is intended to raise awareness of the possibility of the occurrence of ITP relapse post COVID-19 vaccine like other vaccines previously reported. Keywords: COVID-19 vaccination; immune thrombocytopenia; coagulation EN COVID-19 vaccination immune thrombocytopenia coagulation 1 3 3 12/30/22 20220101 NES 220101 Statements Our institution does not require ethical approval for reporting individual cases or case series. One developed de novo ITP after the second dose of Pfizer vaccine which represents 1:1,750,000 of all patients who received both doses of Pfizer vaccine. [Extracted from the article] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
